Press Releases BiomeDx Wins Startup Audience AwardAustrian MedTech Biome Diagnostics convinces investor jury and audience Vienna, November 7, 2022 - Biome…Nikolaus GascheNovember 8, 2022
News & Events Digitization of Life SciencesThe 17th year of International Conference on Genomics by BGI - China's leading genomics company…Nikolaus GascheOctober 30, 2022
News & Events The Advamed MedTech Conference 2022The MedTech Conference is a must attend event for the industry’s prominent and most promising…Nikolaus GascheOctober 26, 2022
News & Events Poster: 55th Austrian Society for Gastroenterology and Hepatology (ÖGGH) 2022BiomeDx presents newest findings on microbiome signatures predicting colorectal cancer and adenoma. VIENNA, September 8th:…Nikolaus GascheSeptember 9, 2022
Publications & Posters ÖGGH 2022: Analysis of colorectal cancer and adenoma microbiome signatures and the application of machine learning classification as a potential screening toolNikolaus GascheSeptember 9, 2022
Publications & Posters Distance-based Techniques for Personal Microbiome IdentificationNikolaus GascheSeptember 7, 2022
Publications & Posters Utility and Privacy Assessment of Synthetic Microbiome DataNikolaus GascheSeptember 7, 2022
Publications & Posters WCLC 2022: Introducing “BiomeOne”, a microbiome-based biomarker to predict immune checkpoint inhibitor response in NSCLC patientsNikolaus GascheAugust 16, 2022
Press Releases Intestinal microbiome as cancer hope: new predictive test makes life easier for patientsVIENNA, July 2022: Vienna-based Biome Diagnostics launches the first and only gut microbiome-based predictive test…Nikolaus GascheJuly 18, 2022
News & Events Is data protection a hurdle or a competitive advantage?Data security is crucial to us! We use the highest standards to do so! Data…Nikolaus GascheFebruary 10, 2022